Weifang Shengtai Medicine Co.,Ltd

Weifang Shengtai Medicine Co., LTD., which is a Wholly Foreign-Owned Enterprise that controlled by U.S. Shengtai Holding Inc., share listed-company of U.S.A. on May, ***7. The company has a registered capital of $*5, **0, **0 and total asset of $*5, **0, **0. Its principal office, which occupies an area of **6, **0 square meters with **6 staffs, is located in Changle Development Zone of Weifang, Shandong Province, China. Weifang Shengtai Medicine Co., LTD. is engaged in production and distribution of Glucose Monohydrate Injection Grade, Glucose Monohydrate Oral Grade, Glucose Anhydrous Injection Grade, Corn Starch, Dextrine, Sodium Gluconate and Avermectins series products. Our products have been passed approval of GMP, HACCP certificates, ISO***0 Quality System certificates and QS certificate. The products of the company have been exported to over *0 countries and areas. Glucose for injection, which is the company's core product, occupies over *0% market share in China, and the sales volume of glucose for injunction ranks No.1 domestically.